Stocks · Health care · Services-Medical Laboratories

Quest Diagnostics

DGX Clue Score42
United States Fiscal year ends December CIK 0001022079 Results filed 22 Oct 2026

What the insiders did Mostly scheduled

Insider
Date
Role
Action
Shares
Price
Amount
Karthik Kuppusamy
4 Mar 2026
SVP, Clinical Solutions
Sell
2,628
$204.86
$538.37K
Vicky B Gregg
25 Nov 2025
Director
Sell
1,250
$191.76
$239.70K
Gary M Pfeiffer
22 Oct 2025
Director
Sell
1,482
$182.40
$270.32K
Patrick Plewman
19 Feb 2025
SVP for Diagnostic Services
Sell
320
$169.71
$54.31K
Mark E Delaney
5 Feb 2025
SVP & Chief Commercial Officer
Sell
403
$164.30
$66.21K
Vicky B Gregg
5 Feb 2025
Director
Sell
1,250
$164.57
$205.71K
Karthik Kuppusamy
28 Oct 2024
SVP, Clinical Solutions
Sell
1,775
$156.92
$278.53K
Karthik Kuppusamy
28 Aug 2024
SVP, Clinical Solutions
Sell
1,990
$153.26
$304.99K
Mark E Delaney
24 Jul 2024
SVP & Chief Commercial Officer
Sell
420
$143.08
$60.09K
Vicky B Gregg
23 Feb 2024
Director
Sell
2,500
$126.64
$316.60K
Catherine T. Doherty
7 Mar 2023
SVP, Regional Businesses
Sell
5,307
$140.55
$745.90K
Michael E Prevoznik
7 Mar 2023
SVP & General Counsel
Sell
4,754
$140.55
$668.17K
Catherine T. Doherty
3 Mar 2023
SVP, Regional Businesses
Sell
717
$140.63
$100.83K
Michael E Prevoznik
2 Mar 2023
SVP & General Counsel
Sell
593
$138.54
$82.15K
Catherine T. Doherty
24 Feb 2023
SVP, Regional Businesses
Sell
1,690
$141.42
$239.00K
Michael E Prevoznik
24 Feb 2023
SVP & General Counsel
Sell
1,415
$141.42
$200.11K
Catherine T. Doherty
8 Mar 2022
SVP, Group Exec. Clin. Fran.
Sell
7,032
$135.21
$950.80K
Michael E Prevoznik
8 Mar 2022
SVP & General Counsel
Sell
6,228
$135.21
$842.09K
Michael E Prevoznik
28 Feb 2022
SVP & General Counsel
Sell
661
$130.00
$85.93K
Michael E Prevoznik
24 Feb 2022
SVP & General Counsel
Sell
1,669
$126.26
$210.73K
Catherine T. Doherty
24 Feb 2022
SVP, Group Exec. Clin. Fran.
Sell
2,750
$126.26
$347.22K
Catherine T. Doherty
7 May 2021
SVP, Group Exec. Clin. Fran.
Sell
8,536
$139.96
$1.19M
Michael E Prevoznik
10 Mar 2021
SVP & General Counsel
Sell
5,574
$120.47
$671.50K
Michael E Prevoznik
25 Feb 2021
SVP & General Counsel
Sell
801
$115.49
$92.51K
Michael E Prevoznik
24 Feb 2021
SVP & General Counsel
Sell
750
$116.95
$87.71K
Michael E Prevoznik
24 Feb 2021
SVP & General Counsel
Sell
438
$116.95
$51.22K
Daniel Stanzione
23 Nov 2020
Director
Sell
2,300
$127.45
$293.14K
Daniel Stanzione
23 Nov 2020
Director
Sell
3,302
$126.46
$417.58K
Daniel Stanzione
23 Nov 2020
Director
Sell
5,621
$125.73
$706.74K
Manner Carrie Eglinton
27 Apr 2020
SVP, Advanced Diagnostics
Sell
2,500
$110.00
$275.00K
Manner Carrie Eglinton
27 Apr 2020
SVP, Advanced Diagnostics
Sell
2,500
$112.03
$280.08K
J. E. Davis
16 Mar 2020
EVP, General Diagnostics
Sell
500
$90.15
$45.07K
J. E. Davis
16 Mar 2020
EVP, General Diagnostics
Sell
421
$88.53
$37.27K
J. E. Davis
16 Mar 2020
EVP, General Diagnostics
Sell
1,307
$87.81
$114.77K
J. E. Davis
16 Mar 2020
EVP, General Diagnostics
Sell
1,085
$86.65
$94.02K
J. E. Davis
16 Mar 2020
EVP, General Diagnostics
Sell
200
$85.59
$17.12K
Catherine T. Doherty
11 Mar 2020
SVP, Group Exec. Clin. Fran.
Sell
2,501
$104.25
$260.73K
Michael E Prevoznik
11 Mar 2020
SVP & General Counsel
Sell
2,175
$104.25
$226.74K
J. E. Davis
27 Feb 2020
EVP, General Diagnostics
Sell
1,100
$109.02
$119.92K
Catherine T. Doherty
27 Feb 2020
SVP, Group Exec. Clin. Fran.
Sell
789
$109.02
$86.02K
Michael E Prevoznik
27 Feb 2020
SVP & General Counsel
Sell
690
$109.02
$75.22K
J. E. Davis
26 Feb 2020
EVP, General Diagnostics
Sell
510
$111.09
$56.66K
Catherine T. Doherty
26 Feb 2020
SVP, Group Exec. Clin. Fran.
Sell
368
$111.09
$40.88K
Michael E Prevoznik
26 Feb 2020
SVP & General Counsel
Sell
321
$111.09
$35.66K
Catherine T. Doherty
25 Feb 2020
SVP, Group Exec. Clin. Fran.
Sell
405
$112.73
$45.66K
J. E. Davis
25 Feb 2020
EVP, General Diagnostics
Sell
598
$112.73
$67.41K
J. E. Davis
8 Apr 2019
EVP, General Diagnostics
Sell
2,100
$90.70
$190.48K
J. E. Davis
8 Apr 2019
EVP, General Diagnostics
Sell
5,900
$90.15
$531.86K
Everett Cunningham
4 Mar 2019
SVP, Commercial
Sell
3,892
$86.81
$337.86K
Michael E Prevoznik
4 Mar 2019
SVP & General Counsel
Sell
3,373
$86.81
$292.81K
Everett Cunningham
27 Feb 2019
SVP, Commercial
Sell
1,144
$86.51
$98.97K
Michael E Prevoznik
27 Feb 2019
SVP & General Counsel
Sell
1,048
$86.51
$90.66K
Everett Cunningham
26 Feb 2019
SVP, Commercial
Sell
352
$87.06
$30.65K
Michael E Prevoznik
26 Feb 2019
SVP & General Counsel
Sell
364
$87.06
$31.69K
Everett Cunningham
25 Feb 2019
SVP, Commercial
Sell
326
$88.23
$28.76K
Michael E Prevoznik
25 Feb 2019
SVP & General Counsel
Sell
336
$88.23
$29.65K
Jeffrey M Leiden
29 May 2018
Director
Sell
1,644
$105.61
$173.62K
Catherine T. Doherty
5 Mar 2018
SVP, Group Exec. Clin. Fran.
Sell
5,556
$101.00
$561.16K
J. E. Davis
5 Mar 2018
EVP, General Diagnostics
Sell
5,122
$101.00
$517.32K
Michael E Prevoznik
5 Mar 2018
SVP & General Counsel
Sell
4,128
$101.00
$416.93K
J. E. Davis
28 Feb 2018
EVP, General Diagnostics
Sell
648
$104.99
$68.03K
Catherine T. Doherty
28 Feb 2018
SVP, Group Exec. Clin. Fran.
Sell
572
$104.99
$60.05K
Michael E Prevoznik
28 Feb 2018
SVP & General Counsel
Sell
496
$104.99
$52.08K
J. E. Davis
27 Feb 2018
EVP, General Diagnostics
Sell
1,150
$104.10
$119.72K
Catherine T. Doherty
27 Feb 2018
SVP, Group Exec. Clin. Fran.
Sell
1,248
$104.10
$129.92K
Michael E Prevoznik
27 Feb 2018
SVP & General Counsel
Sell
927
$104.10
$96.50K
J. E. Davis
26 Feb 2018
EVP, General Diagnostics
Sell
494
$102.74
$50.75K
Catherine T. Doherty
26 Feb 2018
SVP, Group Exec. Clin. Fran.
Sell
397
$102.74
$40.79K
Robert A Klug
26 Feb 2018
VP, Corporate Controller
Sell
1,157
$103.66
$119.93K
Showing 250 of 295 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 656
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 50
Sales straight out of an exercise 166
Sales at will 79
Transactions with no price 0
Shares from compensation/vesting 5,989,127
Sales filed before the plan box existed 69
History held since 3 Oct 2006